Literature DB >> 8528707

Effects of gender on the central actions of neuropeptide Y and norepinephrine on vasopressin and blood pressure in the rat.

K Sato1, J T Crofton, Y X Wang, L Share.   

Abstract

Neuropeptide Y (NPY) and norepinephrine are co-localized in the noradrenergic projection from the A1 nucleus of the medulla to the vasopressinergic magnocellular neurons of the supraoptic and paraventricular nuclei. Because this pathway is involved in the control of vasopressin release, we have examined the possibility that NPY and norepinephrine interact in this control. Because the stimulation of vasopressin release by the intracerebroventricular (i.c.v.) administration of norepinephrine is greater in male than in female rats, the experiments were carried out in conscious male rats and in female rats in the proestrous and non-proestrous phases of the estrous cycle. NPY (940 pmol i.c.v.) caused small sustained increases in plasma vasopressin concentrations that were greater in proestrous than in non-proestrous females and males. Norepinephrine i.c.v. increased plasma vasopressin levels transiently and to a greater extent in females than males. When NPY and norepinephrine were given together, the pattern of the vasopressin response was similar to that of norepinephrine alone. The magnitude of this response in males and proestrous females did not differ from that to norepinephrine alone; in non-proestrous females the response was twice that to norepinephrine alone. In non-proestrous rats, NPY also enhanced the pressor response to norepinephrine. Thus, NPY interacts centrally with norepinephrine in vasopressin release and cardiovascular function and this effect is dependent upon gender and phase of the estrous cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528707     DOI: 10.1016/0006-8993(95)00454-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Hypothalamic paraventricular nucleus G alpha q subunit protein pathways mediate vasopressin dysregulation and fluid retention in salt-sensitive rats.

Authors:  Richard D Wainford; Daniel R Kapusta
Journal:  Endocrinology       Date:  2010-09-22       Impact factor: 4.736

2.  Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.

Authors:  Dwayne N Jackson; Kevin J Milne; Earl G Noble; J Kevin Shoemaker
Journal:  J Physiol       Date:  2004-10-28       Impact factor: 5.182

3.  Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats.

Authors:  Nicholas W Gilpin; Robert B Stewart; Nancy E Badia-Elder
Journal:  Alcohol       Date:  2008-11       Impact factor: 2.405

4.  Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation.

Authors:  Priscila A Cassaglia; Zhigang Shi; Baoxin Li; Wagner L Reis; Nicholas M Clute-Reinig; Javier E Stern; Virginia L Brooks
Journal:  J Physiol       Date:  2014-02-17       Impact factor: 5.182

5.  Neuropeptide Y-mediated sex- and afferent-specific neurotransmissions contribute to sexual dimorphism of baroreflex afferent function.

Authors:  Yang Liu; Di Wu; Mei-Yu Qu; Jian-Li He; Mei Yuan; Miao Zhao; Jian-Xin Wang; Jian He; Lu-Qi Wang; Xin-Jing Guo; Meng Zuo; Shu-Yang Zhao; Mei-Na Ma; Jun-Nan Li; Weinian Shou; Guo-Fen Qiao; Bai-Yan Li
Journal:  Oncotarget       Date:  2016-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.